Facio-Scapulo-Humeral Dystrophy Clinical Trials in München
2 recruitingMünchen, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
facioscapulohumeral muscular dystrophyFascioscapulohumeral Muscular DystrophyFacio-Scapulo-Humeral Dystrophy+14 more
Avidity Biosciences, Inc.200 enrolled46 locationsNCT07038200
Recruiting
Phase 1Phase 2
Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1
Facio-Scapulo-Humeral Dystrophy
Arrowhead Pharmaceuticals60 enrolled17 locationsNCT06131983